drugset
drugset / Trial / NCT02124213

A Study To Evaluate D1 Receptor Occupancy (RO) Following Single Dose of PF-06412562 In Healthy Male Volunteers

NCT02124213 ↗

Phase 1 Completed 5 enrolled Pfizer
Non-randomizedCrossoverOpen-labelBasic science

Summary

This study will evaluate D1 Receptor Occupancy (RO) following a single dose of PF-06412562 In healthy male volunteers

Timeline

Start
2014-09
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-06412562 Unknown 30 mg —

Indications

No indication recorded.